Richard Carvajal, MD, discusses the importance of a multidisciplinary approach when monitoring patients for immunotherapy toxicities.
Richard Carvajal, MD
Advertisement
Articles by Richard Carvajal, MD
Richard Carvajal, MD, discusses how to make decisions regarding the dosing limits of immunotherapy agents.
Advertisement
Latest Updated Articles
Richard Carvajal on Immunotherapy DosingFebruary 13th 2017
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Managing Rash and Stomatitis With Daraxonrasib in Pancreatic Cancer
2
FDA Approves Oral Nilotinib Tablets for Ph+ CML
3
Nursing Guide to Managing Lorlatinib in ALK+ NSCLC: 7-Year CROWN Insights
4
GLP-1 RAs Linked to Lower HR+ Breast Cancer Risk and Improved Survival
5